Results 201 to 210 of about 191,054 (269)

Distinct blood volume and left ventricular adaptation to severe obesity in middle‐aged adults at risk for heart failure

European Journal of Heart Failure, EarlyView.
Obesity, blood volume and ventricular remodelling. BMI, body mass index; DEXA, dual‐energy X‐ray absorptiometry; IR, increased risk; LVEDV, left ventricular end‐diastolic volume; LVEDVi, left ventricular end‐diastolic volume index. Created in BioRender. Wakeham, D.
Joseph Campain, Denis J. Wakeham, Katrin Dias, James P. MacNamara, Mitchel Samels, Erin J Howden, Graeme Carrick‐Ranson, Michinari Hieda, Benjamin D. Levine, Satyam Sarma, Christopher M. Hearon Jr   +10 more
wiley   +1 more source

TAVI for Bicuspid Aortic Valve: Addressing Technical Challenges and Optimizing Outcomes. [PDF]

J Clin Med
Paglianiti DA, Aurigemma C, Busco M, Cappannoli L, Bianchini F, Romagnoli E, Lunardi M, Fracassi F, Paraggio L, Buffon A, Montone RA, Leone AM, Trani C, Burzotta F.   +13 more
europepmc   +1 more source

Diagnostic Challenges of Quadricuspid Aortic Valve

Roberto Cintra A. Aragao, Amanda Raquel Costa Cruz, Iana Carine Machado Bispo, Vitor de Andrade Vahle, Luiz Flavio Galvao Goncalves, José Augusto Soares Barreto-Filho   +5 more
openalex   +2 more sources

Cardiovascular magnetic resonance‐estimated pulmonary capillary wedge pressure, congestion markers, and effect of empagliflozin in patients with heart failure with reduced ejection fraction and dysglycaemia (SUGAR‐DM‐HF)

European Journal of Heart Failure, EarlyView.
Joanna Osmanska, Kieran F. Docherty, Colin Berry, Pardeep S. Jhund, Kenneth Mangion, Patrick B. Mark, John J.V. McMurray, Giles Roditi, Naveed Sattar, Mark C. Petrie, Ross T. Campbell, Matthew M.Y. Lee   +11 more
wiley   +1 more source

Deep phenotyping of heart failure with preserved ejection fraction through multi‐omics integration

European Journal of Heart Failure, EarlyView.
Deep phenotyping of of heart failure with preserved ejection fraction (HFpEF) through multi‐omics integration. AI, artificial intelligence. Aims Heart failure with preserved ejection fraction (HFpEF) has become the predominant form of heart failure and a leading cause of global cardiovascular morbidity and mortality.
Jakob Versnjak, Titus Kuehne, Pauline Fahjen, Nina Jovanovic, Ulrike Löber, Gabriele G. Schiattarella, Nicola Wilck, Holger Gerhardt, Dominik N. Müller, Frank Edelmann, Philipp Mertins, Roland Eils, Michael Gotthardt, Sofia K. Forslund, Benjamin Wild, Marcus Kelm   +15 more
wiley   +1 more source

Heyde's Syndrome: Presentation and Successful Treatment With Transcatheter Aortic Valve Implantation (TAVI). [PDF]

Cureus
Henshall A, Ambrogetti R, De Palma R.
europepmc   +1 more source

Replacing the valve restoring the flow: Effects of transcatheter aortic valve implantation

, 2016
Esther Wiegerinck
openalex   +1 more source

European Journal of Heart Failure expert consensus statement on transcatheter treatment of mitral regurgitation in heart failure

European Journal of Heart Failure, EarlyView.
The patient with SMR: From diagnostic assessment to treatment. Secondary mitral regurgitation (SMR) is highly prevalent in patients with heart failure (HF), associated with poor prognosis, and its treatment is typically preceded by implementing pharmacotherapy for HF as well as cardiac resynchronization therapy.
Christos Iliadis, Marianna Adamo, Volker Rudolph, Nicole Karam, Ralph Stephan von Bardeleben, Stefan D. Anker, Victoria Delgado, Jörg Hausleiter, Hannah Kempton, Marco Metra, Michael Böhm, Stephan Baldus   +11 more
wiley   +1 more source

The role of elevated lipoprotein(a) in aortic valve disease: a systematic review. [PDF]

Front Cardiovasc Med
Wambua P, Wahinya M, Khan Z.
europepmc   +1 more source

Transcatheter aortic valve implantation with Navitor Titan device: First Polish experience

Jarosław Trębacz, Robert Sobczyński, Janusz Konstanty‐Kalandyk, Maciej Stąpór, Michał Okarski, Bogusław Kapelak, Paweł Kleczyński, Jacek Legutko   +7 more
openalex   +1 more source